Patients with chronic rhinosinusitis with nasal polyps show high treatment persistence with dupilumab, with a substantial proportion restarting therapy after discontinuation.

In adults with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, the ...

The risk for SARS-CoV-2 infection is increased among adults with allergic rhinitis using nasal corticosteroids but not among children.

In a study known as CROWNS-2 published in JAMA, the researchers randomly assigned 180 adults with CRSwNP to stapokibart (300 ...

For nearly a decade, 71-year-old Ho Thian Kong struggled with the effects of chronic rhinosinusitis with nasal polyps, a ...

For severe chronic rhinosinusitis with nasal polyps, the novel monoclonal antibody stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid. The polyp size ...

Among patients with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, stapokibart, a ...

Among patients with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, stapokibart, a novel monoclonal antibody, reduced polyp size and severity of nasal ...